148 related articles for article (PubMed ID: 32970939)
1. Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation.
Yuile A; Fanuli C; van Nunen S; Diakos C; Clarke S; Steiner C; MacMillan R; Oatley M; Pavlakis N
Asia Pac J Clin Oncol; 2021 Dec; 17(6):448-453. PubMed ID: 32970939
[TBL] [Abstract][Full Text] [Related]
2. Alpha-Gal-containing biologics and anaphylaxis.
Chinuki Y; Morita E
Allergol Int; 2019 Jul; 68(3):296-300. PubMed ID: 31053502
[TBL] [Abstract][Full Text] [Related]
3. Cohort study of subclinical sensitization against galactose-α-1,3-galactose in Japan: Prevalence and regional variations.
Nakagawa Y; Chinuki Y; Ogino R; Yamasaki K; Aiba S; Ugajin T; Yokozeki H; Kitamura K; Morita E
J Dermatol; 2022 Dec; 49(12):1268-1277. PubMed ID: 36093796
[TBL] [Abstract][Full Text] [Related]
4. Anaphylaxis to the carbohydrate side chain alpha-gal.
Platts-Mills TA; Schuyler AJ; Tripathi A; Commins SP
Immunol Allergy Clin North Am; 2015 May; 35(2):247-60. PubMed ID: 25841549
[TBL] [Abstract][Full Text] [Related]
5. Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat.
Commins SP; Jerath MR; Cox K; Erickson LD; Platts-Mills T
Allergol Int; 2016 Jan; 65(1):16-20. PubMed ID: 26666477
[TBL] [Abstract][Full Text] [Related]
6. Delayed anaphylaxis to red meat in patients with IgE specific for galactose alpha-1,3-galactose (alpha-gal).
Commins SP; Platts-Mills TA
Curr Allergy Asthma Rep; 2013 Feb; 13(1):72-7. PubMed ID: 23054628
[TBL] [Abstract][Full Text] [Related]
7. Food allergy to the carbohydrate galactose-alpha-1,3-galactose (alpha-gal): four case reports and a review.
Bircher AJ; Hofmeier KS; Link S; Heijnen I
Eur J Dermatol; 2017 Feb; 27(1):3-9. PubMed ID: 27873733
[TBL] [Abstract][Full Text] [Related]
8. The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactose.
Commins SP; James HR; Kelly LA; Pochan SL; Workman LJ; Perzanowski MS; Kocan KM; Fahy JV; Nganga LW; Ronmark E; Cooper PJ; Platts-Mills TA
J Allergy Clin Immunol; 2011 May; 127(5):1286-93.e6. PubMed ID: 21453959
[TBL] [Abstract][Full Text] [Related]
9. Fatal anaphylaxis due to alpha-gal syndrome after initial cetuximab administration: The first forensic case report.
Wen S; Unuma K; Chinuki Y; Hikino H; Uemura K
Leg Med (Tokyo); 2021 Jul; 51():101878. PubMed ID: 33892262
[TBL] [Abstract][Full Text] [Related]
10. Drug allergens and food--the cetuximab and galactose-α-1,3-galactose story.
Berg EA; Platts-Mills TA; Commins SP
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):97-101. PubMed ID: 24468247
[TBL] [Abstract][Full Text] [Related]
11. Galactose-α-1,3-galactose (alpha-gal) allergy: first pediatric case in a series of patients in Spain.
Martín-Lázaro J; Núñez-Orjales R; González-Guzmán LA; González MT; Boquete M; Carballada F
Allergol Immunopathol (Madr); 2020; 48(3):251-258. PubMed ID: 31718865
[TBL] [Abstract][Full Text] [Related]
12. Environmental and Molecular Drivers of the α-Gal Syndrome.
Cabezas-Cruz A; Hodžić A; Román-Carrasco P; Mateos-Hernández L; Duscher GG; Sinha DK; Hemmer W; Swoboda I; Estrada-Peña A; de la Fuente J
Front Immunol; 2019; 10():1210. PubMed ID: 31214181
[TBL] [Abstract][Full Text] [Related]
13. Tick-induced allergies: mammalian meat allergy, tick anaphylaxis and their significance.
van Nunen S
Asia Pac Allergy; 2015 Jan; 5(1):3-16. PubMed ID: 25653915
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Serological Characterization of the α-Gal Syndrome-Importance of Atopy for Symptom Severity in a European Cohort.
Kiewiet MBG; Apostolovic D; Starkhammar M; Grundström J; Hamsten C; van Hage M
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):2027-2034.e2. PubMed ID: 32142962
[TBL] [Abstract][Full Text] [Related]
15. Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection.
Park KH; Lee J; Beom SH; Shin SJ; Ahn JB; Kim SR; Lee JH; Park JW
World Allergy Organ J; 2021 Jul; 14(7):100553. PubMed ID: 34257795
[TBL] [Abstract][Full Text] [Related]
16. The alpha-gal story: lessons learned from connecting the dots.
Steinke JW; Platts-Mills TA; Commins SP
J Allergy Clin Immunol; 2015 Mar; 135(3):589-96; quiz 597. PubMed ID: 25747720
[TBL] [Abstract][Full Text] [Related]
17. [Update on meat allergy. α-Gal: a new epitope, a new entity?].
Jappe U
Hautarzt; 2012 Apr; 63(4):299-306. PubMed ID: 22418768
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of type I sensitization to alpha-gal in forest service employees and hunters.
Fischer J; Lupberger E; Hebsaker J; Blumenstock G; Aichinger E; Yazdi AS; Reick D; Oehme R; Biedermann T
Allergy; 2017 Oct; 72(10):1540-1547. PubMed ID: 28273338
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Impact of Type I Sensitization to Alpha-Gal in Patients Consulting an Allergy Unit.
Fischer J; Huynh HN; Hebsaker J; Forchhammer S; Yazdi AS
Int Arch Allergy Immunol; 2020; 181(2):119-127. PubMed ID: 31805569
[TBL] [Abstract][Full Text] [Related]
20. Galactose-α-1,3-galactose and delayed anaphylaxis, angioedema, and urticaria in children.
Kennedy JL; Stallings AP; Platts-Mills TA; Oliveira WM; Workman L; James HR; Tripathi A; Lane CJ; Matos L; Heymann PW; Commins SP
Pediatrics; 2013 May; 131(5):e1545-52. PubMed ID: 23569097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
